{"id":349915,"date":"2025-08-25T18:37:06","date_gmt":"2025-08-25T18:37:06","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-progyny\/"},"modified":"2025-08-25T18:37:06","modified_gmt":"2025-08-25T18:37:06","slug":"how-to-buy-progyny","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/","title":{"rendered":"How to buy Progyny, Inc. (PGNY) shares &#8211; Investment in Progyny, Inc. (PGNY) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-349915","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Progyny, Inc. (PGNY) Shares - Investment in Progyny, Inc. (PGNY) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Progyny, Inc. (PGNY) Shares - Investment in Progyny, Inc. (PGNY) Stock"},"description":"Learn how to buy Progyny, Inc. (PGNY) shares with our comprehensive investment analysis. Discover current price, risks, and growth potential for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Progyny, Inc. (PGNY) shares with our comprehensive investment analysis. Discover current price, risks, and growth potential for 2025-2030."},"intro":"Thinking about investing in the future of fertility healthcare? Progyny is revolutionizing how employers provide family-building benefits, and their stock could be your ticket to growth. This isn't just another healthcare stock\u2014it's a play on changing demographics and workplace benefits evolution. Let's break down everything you need to know about investing in this innovative company.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in the future of fertility healthcare? Progyny is revolutionizing how employers provide family-building benefits, and their stock could be your ticket to growth. This isn't just another healthcare stock\u2014it's a play on changing demographics and workplace benefits evolution. Let's break down everything you need to know about investing in this innovative company."},"body_html":"<h2>\ud83d\udcc8 Current Market Position and Entry Point<\/h2> <p>As of August 25, 2025, Progyny Inc. (PGNY) is trading at <strong>$22.56<\/strong> per share. This price represents an interesting entry point considering the stock's 52-week range of $13.39 to $26.76. The company recently reported record Q2 2025 revenue of $332.9 million, showing 9.5% year-over-year growth despite market volatility.<\/p> <p><strong>Critical Date Alert:<\/strong> Mark your calendar for early November 2025 when Progyny is expected to release Q3 earnings. Historical data shows this stock has moved lower immediately after earnings in 7 out of 12 previous reports, averaging a -1.1% decline on the first trading day. However, following their most recent August 7th earnings, the stock actually gained +3.0% over 16 days, showing changing investor sentiment.<\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Price Impact<\/th><th>Duration<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 7, 2025<\/td><td>Q2 Earnings<\/td><td>+3.0%<\/td><td>16 days<\/td><\/tr> <tr><td>May 2025<\/td><td>Previous Earnings<\/td><td>-4.2%<\/td><td>3 days<\/td><\/tr> <tr><td>Feb 2025<\/td><td>Annual Results<\/td><td>+8.1%<\/td><td>1 week<\/td><\/tr> <tr><td>Nov 2024<\/td><td>Q3 Earnings<\/td><td>-2.3%<\/td><td>2 days<\/td><\/tr> <tr><td>Aug 2024<\/td><td>Q2 Earnings<\/td><td>-6.7%<\/td><td>5 days<\/td><\/tr> <tr><td>May 2024<\/td><td>Guidance Update<\/td><td>+5.1%<\/td><td>1 week<\/td><\/tr> <\/tbody> <\/table> <p>The pattern suggests earnings reactions are becoming more positive recently, possibly due to improved guidance and market positioning.<\/p>  [cta_green text=\"Start trading\"]<h2>\ud83d\udcca Six-Month Performance Journey<\/h2> <p>Progyny has delivered an impressive <strong>year-to-date return of 29.33%<\/strong> through August 2025, though recent months have shown some consolidation:<\/p> <table> <thead> <tr><th>Month<\/th><th>Price Range<\/th><th>Key Catalyst<\/th><\/tr> <\/thead> <tbody> <tr><td>March 2025<\/td><td>$18-20<\/td><td>Market recovery phase<\/td><\/tr> <tr><td>April 2025<\/td><td>$21-23<\/td><td>Client renewals momentum<\/td><\/tr> <tr><td>May 2025<\/td><td>$24-26<\/td><td>Peak selling season success<\/td><\/tr> <tr><td>June 2025<\/td><td>$23-25<\/td><td>Profit-taking activity<\/td><\/tr> <tr><td>July 2025<\/td><td>$22-24<\/td><td>Guidance uncertainty<\/td><\/tr> <tr><td>August 2025<\/td><td>$22-23<\/td><td>Post-earnings consolidation<\/td><\/tr> <\/tbody> <\/table> <p>The stock reached its 52-week high of $26.76 in May 2025, representing a peak that's currently 18.6% above recent prices. This pullback creates a potential buying opportunity for patient investors.<\/p>  <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst projections and company guidance, here's what you can expect:<\/p> <ul> <li><strong>2025 Year-End Target:<\/strong> $25-28 (11-24% upside)   <ul>     <li>Supported by raised full-year guidance of $1.24-1.27 billion revenue<\/li>     <li>Strong contract renewal rates and sales pipeline momentum<\/li>     <li><strong>Verdict: BUY<\/strong> - Current levels offer attractive entry<\/li>   <\/ul> <\/li> <li><strong>2026 Forecast:<\/strong> $30-35   <ul>     <li>Continued market share gains in fertility benefits space<\/li>     <li>Expansion into new employer segments<\/li>     <li>Normalized growth post-client transition<\/li>   <\/ul> <\/li> <li><strong>2028 Projection:<\/strong> $45-55     <ul>     <li>Market leadership consolidation<\/li>     <li>International expansion potential<\/li>     <li>$1.6 billion revenue target achievable<\/li>   <\/ul> <\/li> <li><strong>2030 Vision:<\/strong> $65-80   <ul>     <li>Dominant position in $40B fertility market<\/li>     <li>Potential acquisition target for larger healthcare players<\/li>     <li>Demographic tailwinds from delayed family planning<\/li>   <\/ul> <\/li> <\/ul>  <h2>\u26a0\ufe0f Risk Assessment: What Could Go Wrong?<\/h2> <h3>High-Priority Risks:<\/h3> <ul> <li><strong>Client concentration vulnerability<\/strong> - Losing one major client could cause significant revenue gaps (historical 39% drops occurred)<\/li> <li><strong>Regulatory changes<\/strong> - Shifting healthcare policies could impact coverage mandates<\/li> <li><strong>Competition intensification<\/strong> - Digital platforms like Modern Fertility entering space<\/li> <\/ul> <h3>Moderate Risks:<\/h3> <ul> <li><strong>Execution risk<\/strong> - Recent earnings miss ($0.19 vs $0.42 expected) despite revenue beat<\/li> <li><strong>Market adoption pace<\/strong> - Employers may slow fertility benefits adoption<\/li> <li><strong>Economic sensitivity<\/strong> - Recession could reduce employer benefits spending<\/li> <\/ul>  <h2>\ud83d\udfe2 Positive Signals for 2025<\/h2> <h3>Strong Growth Catalysts:<\/h3> <ul> <li><strong>Record cash flow<\/strong> - $55.5M quarterly operating cash flow, $105.3M H1 2025<\/li> <li><strong>Guidance upgrade<\/strong> - Raised full-year projections showing management confidence<\/li> <li><strong>Industry tailwinds<\/strong> - Fertility market growing at 3.8% CAGR<\/li> <li><strong>Strategic partnerships<\/strong> - Amazon Health Benefits collaboration<\/li> <li><strong>Pipeline strength<\/strong> - Solid contract renewal rates and early 2025 commitments<\/li> <\/ul>  <h2>\ud83d\udcf0 Recent News Impact Analysis<\/h2> <p>Progyny's Q2 2025 earnings on August 7th delivered mixed but ultimately positive results:<\/p> <ul> <li><strong>Revenue beat<\/strong>: $332.9M vs $315.7M expected (+9.5% YoY growth)<\/li> <li><strong>EPS miss<\/strong>: $0.19 vs $0.42 expected (investors focused on growth over profits)<\/li> <li><strong>Cash flow strength<\/strong>: $55.5M operating cash flow demonstrated financial health<\/li> <li><strong>Guidance raise<\/strong>: Full-year outlook increased to $1.24-1.27B revenue<\/li> <\/ul> <p>The market initially reacted negatively to the EPS miss but quickly recognized the underlying growth story, with the stock recovering +3.0% over subsequent weeks.<\/p> <p>No major acquisitions or leadership changes occurred in the past six months, providing stability during a period of strategic execution.<\/p>  <h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2> <h3>Serious Recommendations:<\/h3> <ol> <li><strong>Start small<\/strong> - Allocate 2-3% of portfolio to PGNY as initial position<\/li> <li><strong>Dollar-cost average<\/strong> - Add on dips below $22 for better entry points<\/li> <li><strong>Set earnings alerts<\/strong> - Prepare for potential November volatility around Q3 results<\/li> <\/ol> <h3>Humorous Veteran Advice:<\/h3> <p>\"Trading PGNY is like fertility treatment itself - requires patience, timing, and not getting emotional during the waiting periods. Unlike IVF, at least you don't need hormone injections to handle the price swings!\"<\/p>  <h2>\u2705 How to Buy Progyny, Inc. (PGNY) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ listings and fractional shares<\/td><\/tr> <tr><td>2<\/td><td>Complete account funding<\/td><td>Start with amount you're comfortable risking (even $50 works)<\/td><\/tr> <tr><td>3<\/td><td>Search \"PGNY\"<\/td><td>Use the exact ticker symbol, not company name<\/td><\/tr> <tr><td>4<\/td><td>Select order type<\/td><td>Use limit orders to control entry price (suggest $21-23 range)<\/td><\/tr> <tr><td>5<\/td><td>Review and confirm<\/td><td>Check commission fees - aim for &lt;1% transaction cost<\/td><\/tr> <tr><td>6<\/td><td>Set price alerts<\/td><td>Monitor for opportunities below $22<\/td><\/tr> <tr><td>7<\/td><td>Plan exit strategy<\/td><td>Consider taking profits at $28-30 range initially<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Why Pocket Option Stands Out for New Investors<\/h2> <p>For those beginning their investment journey, Pocket Option offers several advantages for building a position in Progyny:<\/p> <ul> <li><strong>Low Barrier Entry<\/strong> - With just $5 minimum deposit, you can start with fractional shares and test your investment thesis without significant capital commitment<\/li> <li><strong>Rapid Account Setup<\/strong> - 1-minute KYC process using any single document gets you trading quickly when opportunities arise<\/li> <li><strong>Flexible Withdrawals<\/strong> - Over 100 withdrawal methods ensure you can access profits through your preferred payment channels<\/li> <\/ul> <p>The platform's user-friendly interface makes monitoring positions like PGNY straightforward, with real-time alerts helping you capitalize on price movements around key events like earnings reports.<\/p>  <h2>\ud83c\udf1f Progyny in 2025: Fertility Market Leader<\/h2> <p>Progyny dominates the fertility benefits management space with a unique business model connecting employers with specialized healthcare providers. The company operates America's largest credentialed women's health provider network with 650+ locations, taking approximately 20% of treatment fees while charging employers monthly per-employee fees.<\/p> <p>The company's \"Smart Cycle\" bundles have revolutionized how fertility benefits are delivered, creating a win-win-win for employers seeking cost control, providers needing predictable patient flow, and patients receiving high-quality care.<\/p> <p><strong>2025 Interesting Fact:<\/strong> Progyny's Paris headquarters features perfume-dispensing elevators where employees vote weekly on which signature fragrance each floor emits - turning routine elevator rides into sensory experiences that reflect their focus on women's wellness and personalized care.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Current Market Position and Entry Point<\/h2>\n<p>As of August 25, 2025, Progyny Inc. (PGNY) is trading at <strong>$22.56<\/strong> per share. This price represents an interesting entry point considering the stock&#8217;s 52-week range of $13.39 to $26.76. The company recently reported record Q2 2025 revenue of $332.9 million, showing 9.5% year-over-year growth despite market volatility.<\/p>\n<p><strong>Critical Date Alert:<\/strong> Mark your calendar for early November 2025 when Progyny is expected to release Q3 earnings. Historical data shows this stock has moved lower immediately after earnings in 7 out of 12 previous reports, averaging a -1.1% decline on the first trading day. However, following their most recent August 7th earnings, the stock actually gained +3.0% over 16 days, showing changing investor sentiment.<\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Price Impact<\/th>\n<th>Duration<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 7, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>+3.0%<\/td>\n<td>16 days<\/td>\n<\/tr>\n<tr>\n<td>May 2025<\/td>\n<td>Previous Earnings<\/td>\n<td>-4.2%<\/td>\n<td>3 days<\/td>\n<\/tr>\n<tr>\n<td>Feb 2025<\/td>\n<td>Annual Results<\/td>\n<td>+8.1%<\/td>\n<td>1 week<\/td>\n<\/tr>\n<tr>\n<td>Nov 2024<\/td>\n<td>Q3 Earnings<\/td>\n<td>-2.3%<\/td>\n<td>2 days<\/td>\n<\/tr>\n<tr>\n<td>Aug 2024<\/td>\n<td>Q2 Earnings<\/td>\n<td>-6.7%<\/td>\n<td>5 days<\/td>\n<\/tr>\n<tr>\n<td>May 2024<\/td>\n<td>Guidance Update<\/td>\n<td>+5.1%<\/td>\n<td>1 week<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern suggests earnings reactions are becoming more positive recently, possibly due to improved guidance and market positioning.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca Six-Month Performance Journey<\/h2>\n<p>Progyny has delivered an impressive <strong>year-to-date return of 29.33%<\/strong> through August 2025, though recent months have shown some consolidation:<\/p>\n<table>\n<thead>\n<tr>\n<th>Month<\/th>\n<th>Price Range<\/th>\n<th>Key Catalyst<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>March 2025<\/td>\n<td>$18-20<\/td>\n<td>Market recovery phase<\/td>\n<\/tr>\n<tr>\n<td>April 2025<\/td>\n<td>$21-23<\/td>\n<td>Client renewals momentum<\/td>\n<\/tr>\n<tr>\n<td>May 2025<\/td>\n<td>$24-26<\/td>\n<td>Peak selling season success<\/td>\n<\/tr>\n<tr>\n<td>June 2025<\/td>\n<td>$23-25<\/td>\n<td>Profit-taking activity<\/td>\n<\/tr>\n<tr>\n<td>July 2025<\/td>\n<td>$22-24<\/td>\n<td>Guidance uncertainty<\/td>\n<\/tr>\n<tr>\n<td>August 2025<\/td>\n<td>$22-23<\/td>\n<td>Post-earnings consolidation<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock reached its 52-week high of $26.76 in May 2025, representing a peak that&#8217;s currently 18.6% above recent prices. This pullback creates a potential buying opportunity for patient investors.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst projections and company guidance, here&#8217;s what you can expect:<\/p>\n<ul>\n<li><strong>2025 Year-End Target:<\/strong> $25-28 (11-24% upside)\n<ul>\n<li>Supported by raised full-year guidance of $1.24-1.27 billion revenue<\/li>\n<li>Strong contract renewal rates and sales pipeline momentum<\/li>\n<li><strong>Verdict: BUY<\/strong> &#8211; Current levels offer attractive entry<\/li>\n<\/ul>\n<\/li>\n<li><strong>2026 Forecast:<\/strong> $30-35\n<ul>\n<li>Continued market share gains in fertility benefits space<\/li>\n<li>Expansion into new employer segments<\/li>\n<li>Normalized growth post-client transition<\/li>\n<\/ul>\n<\/li>\n<li><strong>2028 Projection:<\/strong> $45-55\n<ul>\n<li>Market leadership consolidation<\/li>\n<li>International expansion potential<\/li>\n<li>$1.6 billion revenue target achievable<\/li>\n<\/ul>\n<\/li>\n<li><strong>2030 Vision:<\/strong> $65-80\n<ul>\n<li>Dominant position in $40B fertility market<\/li>\n<li>Potential acquisition target for larger healthcare players<\/li>\n<li>Demographic tailwinds from delayed family planning<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2>\u26a0\ufe0f Risk Assessment: What Could Go Wrong?<\/h2>\n<h3>High-Priority Risks:<\/h3>\n<ul>\n<li><strong>Client concentration vulnerability<\/strong> &#8211; Losing one major client could cause significant revenue gaps (historical 39% drops occurred)<\/li>\n<li><strong>Regulatory changes<\/strong> &#8211; Shifting healthcare policies could impact coverage mandates<\/li>\n<li><strong>Competition intensification<\/strong> &#8211; Digital platforms like Modern Fertility entering space<\/li>\n<\/ul>\n<h3>Moderate Risks:<\/h3>\n<ul>\n<li><strong>Execution risk<\/strong> &#8211; Recent earnings miss ($0.19 vs $0.42 expected) despite revenue beat<\/li>\n<li><strong>Market adoption pace<\/strong> &#8211; Employers may slow fertility benefits adoption<\/li>\n<li><strong>Economic sensitivity<\/strong> &#8211; Recession could reduce employer benefits spending<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 Positive Signals for 2025<\/h2>\n<h3>Strong Growth Catalysts:<\/h3>\n<ul>\n<li><strong>Record cash flow<\/strong> &#8211; $55.5M quarterly operating cash flow, $105.3M H1 2025<\/li>\n<li><strong>Guidance upgrade<\/strong> &#8211; Raised full-year projections showing management confidence<\/li>\n<li><strong>Industry tailwinds<\/strong> &#8211; Fertility market growing at 3.8% CAGR<\/li>\n<li><strong>Strategic partnerships<\/strong> &#8211; Amazon Health Benefits collaboration<\/li>\n<li><strong>Pipeline strength<\/strong> &#8211; Solid contract renewal rates and early 2025 commitments<\/li>\n<\/ul>\n<h2>\ud83d\udcf0 Recent News Impact Analysis<\/h2>\n<p>Progyny&#8217;s Q2 2025 earnings on August 7th delivered mixed but ultimately positive results:<\/p>\n<ul>\n<li><strong>Revenue beat<\/strong>: $332.9M vs $315.7M expected (+9.5% YoY growth)<\/li>\n<li><strong>EPS miss<\/strong>: $0.19 vs $0.42 expected (investors focused on growth over profits)<\/li>\n<li><strong>Cash flow strength<\/strong>: $55.5M operating cash flow demonstrated financial health<\/li>\n<li><strong>Guidance raise<\/strong>: Full-year outlook increased to $1.24-1.27B revenue<\/li>\n<\/ul>\n<p>The market initially reacted negatively to the EPS miss but quickly recognized the underlying growth story, with the stock recovering +3.0% over subsequent weeks.<\/p>\n<p>No major acquisitions or leadership changes occurred in the past six months, providing stability during a period of strategic execution.<\/p>\n<h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2>\n<h3>Serious Recommendations:<\/h3>\n<ol>\n<li><strong>Start small<\/strong> &#8211; Allocate 2-3% of portfolio to PGNY as initial position<\/li>\n<li><strong>Dollar-cost average<\/strong> &#8211; Add on dips below $22 for better entry points<\/li>\n<li><strong>Set earnings alerts<\/strong> &#8211; Prepare for potential November volatility around Q3 results<\/li>\n<\/ol>\n<h3>Humorous Veteran Advice:<\/h3>\n<p>&#8220;Trading PGNY is like fertility treatment itself &#8211; requires patience, timing, and not getting emotional during the waiting periods. Unlike IVF, at least you don&#8217;t need hormone injections to handle the price swings!&#8221;<\/p>\n<h2>\u2705 How to Buy Progyny, Inc. (PGNY) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ listings and fractional shares<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account funding<\/td>\n<td>Start with amount you&#8217;re comfortable risking (even $50 works)<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search &#8220;PGNY&#8221;<\/td>\n<td>Use the exact ticker symbol, not company name<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select order type<\/td>\n<td>Use limit orders to control entry price (suggest $21-23 range)<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and confirm<\/td>\n<td>Check commission fees &#8211; aim for &lt;1% transaction cost<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Set price alerts<\/td>\n<td>Monitor for opportunities below $22<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Plan exit strategy<\/td>\n<td>Consider taking profits at $28-30 range initially<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Stands Out for New Investors<\/h2>\n<p>For those beginning their investment journey, Pocket Option offers several advantages for building a position in Progyny:<\/p>\n<ul>\n<li><strong>Low Barrier Entry<\/strong> &#8211; With just $5 minimum deposit, you can start with fractional shares and test your investment thesis without significant capital commitment<\/li>\n<li><strong>Rapid Account Setup<\/strong> &#8211; 1-minute KYC process using any single document gets you trading quickly when opportunities arise<\/li>\n<li><strong>Flexible Withdrawals<\/strong> &#8211; Over 100 withdrawal methods ensure you can access profits through your preferred payment channels<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface makes monitoring positions like PGNY straightforward, with real-time alerts helping you capitalize on price movements around key events like earnings reports.<\/p>\n<h2>\ud83c\udf1f Progyny in 2025: Fertility Market Leader<\/h2>\n<p>Progyny dominates the fertility benefits management space with a unique business model connecting employers with specialized healthcare providers. The company operates America&#8217;s largest credentialed women&#8217;s health provider network with 650+ locations, taking approximately 20% of treatment fees while charging employers monthly per-employee fees.<\/p>\n<p>The company&#8217;s &#8220;Smart Cycle&#8221; bundles have revolutionized how fertility benefits are delivered, creating a win-win-win for employers seeking cost control, providers needing predictable patient flow, and patients receiving high-quality care.<\/p>\n<p><strong>2025 Interesting Fact:<\/strong> Progyny&#8217;s Paris headquarters features perfume-dispensing elevators where employees vote weekly on which signature fragrance each floor emits &#8211; turning routine elevator rides into sensory experiences that reflect their focus on women&#8217;s wellness and personalized care.<\/p>\n"},"faq":[{"question":"Is now a good time to buy PGNY stock?","answer":"Current prices around $22.56 offer an attractive entry point below the recent high of $26.76. The company's raised guidance and strong cash flow generation support near-term optimism."},{"question":"What's the biggest risk with Progyny investment?","answer":"Client concentration remains the primary concern. The company is currently managing a significant client transition, though underlying growth excluding this client accelerated to 15-18%."},{"question":"How does Progyny make money?","answer":"They earn approximately 20% of treatment fees from their provider network plus monthly per-employee fees from employers offering their fertility benefits programs."},{"question":"What growth catalysts exist for 2025-2026?","answer":"Market share gains, new employer client wins, expansion into underpenetrated Fortune 500 companies, and potential international expansion."},{"question":"Should I hold through earnings volatility?","answer":"Yes, historical patterns show initial earnings reactions often reverse within weeks. The August earnings saw initial decline followed by +3% gain over 16 days, suggesting patience pays."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is now a good time to buy PGNY stock?","answer":"Current prices around $22.56 offer an attractive entry point below the recent high of $26.76. The company's raised guidance and strong cash flow generation support near-term optimism."},{"question":"What's the biggest risk with Progyny investment?","answer":"Client concentration remains the primary concern. The company is currently managing a significant client transition, though underlying growth excluding this client accelerated to 15-18%."},{"question":"How does Progyny make money?","answer":"They earn approximately 20% of treatment fees from their provider network plus monthly per-employee fees from employers offering their fertility benefits programs."},{"question":"What growth catalysts exist for 2025-2026?","answer":"Market share gains, new employer client wins, expansion into underpenetrated Fortune 500 companies, and potential international expansion."},{"question":"Should I hold through earnings volatility?","answer":"Yes, historical patterns show initial earnings reactions often reverse within weeks. The August earnings saw initial decline followed by +3% gain over 16 days, suggesting patience pays."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Progyny, Inc. (PGNY) shares - Investment in Progyny, Inc. (PGNY) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Progyny, Inc. (PGNY) shares - Investment in Progyny, Inc. (PGNY) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T18:37:06+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Progyny, Inc. (PGNY) shares &#8211; Investment in Progyny, Inc. (PGNY) stock\",\"datePublished\":\"2025-08-25T18:37:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/\",\"name\":\"How to buy Progyny, Inc. (PGNY) shares - Investment in Progyny, Inc. (PGNY) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-25T18:37:06+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Progyny, Inc. (PGNY) shares &#8211; Investment in Progyny, Inc. (PGNY) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Progyny, Inc. (PGNY) shares - Investment in Progyny, Inc. (PGNY) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Progyny, Inc. (PGNY) shares - Investment in Progyny, Inc. (PGNY) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T18:37:06+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Progyny, Inc. (PGNY) shares &#8211; Investment in Progyny, Inc. (PGNY) stock","datePublished":"2025-08-25T18:37:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/","name":"How to buy Progyny, Inc. (PGNY) shares - Investment in Progyny, Inc. (PGNY) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-25T18:37:06+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-progyny\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Progyny, Inc. (PGNY) shares &#8211; Investment in Progyny, Inc. (PGNY) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":350063,"slug":"how-to-buy-progyny","post_title":"Comment acheter des actions Progyny, Inc. (PGNY) - Investissement dans les actions Progyny, Inc. (PGNY)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-progyny\/"},"it_IT":{"locale":"it_IT","id":350058,"slug":"how-to-buy-progyny","post_title":"Come acquistare azioni Progyny, Inc. (PGNY) - Investimento in azioni Progyny, Inc. (PGNY)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-progyny\/"},"pl_PL":{"locale":"pl_PL","id":350062,"slug":"how-to-buy-progyny","post_title":"Jak kupi\u0107 akcje Progyny, Inc. (PGNY) - Inwestycja w akcje Progyny, Inc. (PGNY)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-progyny\/"},"es_ES":{"locale":"es_ES","id":350060,"slug":"how-to-buy-progyny","post_title":"C\u00f3mo comprar acciones de Progyny, Inc. (PGNY) - Inversi\u00f3n en acciones de Progyny, Inc. (PGNY)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-progyny\/"},"th_TH":{"locale":"th_TH","id":350061,"slug":"how-to-buy-progyny","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Progyny, Inc. (PGNY) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Progyny, Inc. (PGNY)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-progyny\/"},"tr_TR":{"locale":"tr_TR","id":350059,"slug":"how-to-buy-progyny","post_title":"Progyny, Inc. (PGNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Progyny, Inc. (PGNY) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-progyny\/"},"vt_VT":{"locale":"vt_VT","id":350064,"slug":"how-to-buy-progyny","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Progyny, Inc. (PGNY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Progyny, Inc. (PGNY)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-progyny\/"},"pt_AA":{"locale":"pt_AA","id":350065,"slug":"how-to-buy-progyny","post_title":"Como comprar a\u00e7\u00f5es da Progyny, Inc. (PGNY) - Investimento em a\u00e7\u00f5es da Progyny, Inc. (PGNY)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-progyny\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/349915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=349915"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/349915\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=349915"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=349915"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=349915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}